Altasciences to guide development of RAP-103 peptide as chemical nerve agent therapeutic May 23, 2019 No Comments
Phase II study of AXS-05 for smoking cessation meets prespecified primary endpoint April 16, 2019 No Comments
GPR39 agonist reduces alcohol intake in mouse model of alcohol use disorder Feb. 19, 2019 No Comments
Addex and Indivior intend to accelerate additional GABA-B PAM compounds for addiction Feb. 14, 2019 No Comments
RSS